Insights into primary ovarian insufficiency through genetically engineered mouse models

Shannon D. Sullivan, Diego H. Castrillon

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a form of hypergonadotropic hypogonadism that causes infertility in ~1% of women <40 years of age. POI has important health consequences for affected patients; however, the mechanisms that cause ovarian dysfunction are poorly understood. Elucidating these mechanisms is paramount to developing better testing and treatment strategies for affected girls and women. For obvious reasons, studies looking directly at the human ovary are extremely limited. Recently, numerous genetically engineered mouse models have been developed to investigate the molecular mechanisms that may be involved in the pathogenesis of POI. Two potential mechanisms may be involved in the development of POI: (1) abnormalities in primordial follicle activation and (2) increased rates of apoptosis of oocytes. Each of these mechanisms may lead to early depletion of ovarian follicular reserve, and thus be a contributing factor in POI. This review addresses current knowledge of molecular mechanisms controlling primordial follicle activation and oocyte apoptosis, as evidenced from various genetic mouse models. Translation of these data into clinically effective treatments or even prevention strategies may improve fertility and quality of life for women with this form of reproductive dysfunction.

Original languageEnglish (US)
Pages (from-to)283-298
Number of pages16
JournalSeminars in Reproductive Medicine
Volume29
Issue number4
DOIs
StatePublished - 2011

Fingerprint

Primary Ovarian Insufficiency
Oocytes
Apoptosis
Hypogonadism
Genetic Models
Infertility
Fertility
Ovary
Quality of Life
Health
Therapeutics

Keywords

  • apoptosis
  • mouse model
  • premature ovarian failure
  • Primary ovarian insufficiency
  • primordial follicle activation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Insights into primary ovarian insufficiency through genetically engineered mouse models. / Sullivan, Shannon D.; Castrillon, Diego H.

In: Seminars in Reproductive Medicine, Vol. 29, No. 4, 2011, p. 283-298.

Research output: Contribution to journalArticle

@article{5fd1746b261e4c3ca89312529f80515c,
title = "Insights into primary ovarian insufficiency through genetically engineered mouse models",
abstract = "Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a form of hypergonadotropic hypogonadism that causes infertility in ~1{\%} of women <40 years of age. POI has important health consequences for affected patients; however, the mechanisms that cause ovarian dysfunction are poorly understood. Elucidating these mechanisms is paramount to developing better testing and treatment strategies for affected girls and women. For obvious reasons, studies looking directly at the human ovary are extremely limited. Recently, numerous genetically engineered mouse models have been developed to investigate the molecular mechanisms that may be involved in the pathogenesis of POI. Two potential mechanisms may be involved in the development of POI: (1) abnormalities in primordial follicle activation and (2) increased rates of apoptosis of oocytes. Each of these mechanisms may lead to early depletion of ovarian follicular reserve, and thus be a contributing factor in POI. This review addresses current knowledge of molecular mechanisms controlling primordial follicle activation and oocyte apoptosis, as evidenced from various genetic mouse models. Translation of these data into clinically effective treatments or even prevention strategies may improve fertility and quality of life for women with this form of reproductive dysfunction.",
keywords = "apoptosis, mouse model, premature ovarian failure, Primary ovarian insufficiency, primordial follicle activation",
author = "Sullivan, {Shannon D.} and Castrillon, {Diego H.}",
year = "2011",
doi = "10.1055/s-0031-1280914",
language = "English (US)",
volume = "29",
pages = "283--298",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Insights into primary ovarian insufficiency through genetically engineered mouse models

AU - Sullivan, Shannon D.

AU - Castrillon, Diego H.

PY - 2011

Y1 - 2011

N2 - Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a form of hypergonadotropic hypogonadism that causes infertility in ~1% of women <40 years of age. POI has important health consequences for affected patients; however, the mechanisms that cause ovarian dysfunction are poorly understood. Elucidating these mechanisms is paramount to developing better testing and treatment strategies for affected girls and women. For obvious reasons, studies looking directly at the human ovary are extremely limited. Recently, numerous genetically engineered mouse models have been developed to investigate the molecular mechanisms that may be involved in the pathogenesis of POI. Two potential mechanisms may be involved in the development of POI: (1) abnormalities in primordial follicle activation and (2) increased rates of apoptosis of oocytes. Each of these mechanisms may lead to early depletion of ovarian follicular reserve, and thus be a contributing factor in POI. This review addresses current knowledge of molecular mechanisms controlling primordial follicle activation and oocyte apoptosis, as evidenced from various genetic mouse models. Translation of these data into clinically effective treatments or even prevention strategies may improve fertility and quality of life for women with this form of reproductive dysfunction.

AB - Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a form of hypergonadotropic hypogonadism that causes infertility in ~1% of women <40 years of age. POI has important health consequences for affected patients; however, the mechanisms that cause ovarian dysfunction are poorly understood. Elucidating these mechanisms is paramount to developing better testing and treatment strategies for affected girls and women. For obvious reasons, studies looking directly at the human ovary are extremely limited. Recently, numerous genetically engineered mouse models have been developed to investigate the molecular mechanisms that may be involved in the pathogenesis of POI. Two potential mechanisms may be involved in the development of POI: (1) abnormalities in primordial follicle activation and (2) increased rates of apoptosis of oocytes. Each of these mechanisms may lead to early depletion of ovarian follicular reserve, and thus be a contributing factor in POI. This review addresses current knowledge of molecular mechanisms controlling primordial follicle activation and oocyte apoptosis, as evidenced from various genetic mouse models. Translation of these data into clinically effective treatments or even prevention strategies may improve fertility and quality of life for women with this form of reproductive dysfunction.

KW - apoptosis

KW - mouse model

KW - premature ovarian failure

KW - Primary ovarian insufficiency

KW - primordial follicle activation

UR - http://www.scopus.com/inward/record.url?scp=80053921589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053921589&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1280914

DO - 10.1055/s-0031-1280914

M3 - Article

C2 - 21972066

AN - SCOPUS:80053921589

VL - 29

SP - 283

EP - 298

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 4

ER -